Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Dermatology

Derm Allergy/Immunology

Assessment of changes in color and size of vitiligo lesions during treatment with narrow band ultraviolet B

Journal of Cosmetic Dermatology | Nov 26, 2021 Derm Allergy/Immunology

Risk of progression to autoimmune disease in severe drug eruption: Risk factors and the factor-guided stratification

Journal of Investigative Dermatology | Nov 25, 2021 Derm Allergy/Immunology

Safety of tacrolimus 0.03% and 0.1% ointments in young children with atopic dermatitis: A 36-month follow-up study

Clinical and Experimental Dermatology | Nov 25, 2021 Derm Allergy/Immunology

Efficacy of narrow band UVB with or without OMP in stabilization of vitiligo activity in skin photo-types (III–V): A double-blind, randomized, placebo-controlled, prospective, multicenter study

Photodermatology, Photoimmunology and Photomedicine | Nov 24, 2021 Derm Allergy/Immunology

Association between atopic dermatitis and height, body mass index, and weight in children

JAMA | Nov 23, 2021 Derm Allergy/Immunology

Comparison of treatments for H ₁ antihistamine–refractory chronic spontaneous urticaria

JAMA | Nov 22, 2021 Derm Allergy/Immunology

Efficacy and safety of oral nalbuphine extended release in prurigo nodularis: Results of a phase 2 randomized controlled trial with an open‐label extension phase

Journal of the European Academy of Dermatology and Venereology | Nov 21, 2021 Derm Allergy/Immunology

Interleukin 38 serum level is increased in patients with vitiligo, correlated with disease severity, and associated with signs of disease activity

Journal of Cosmetic Dermatology | Nov 19, 2021 Derm Allergy/Immunology

Thalidomide treatment for patients with chronic erythema multiforme

JAMA | Nov 17, 2021 Derm Allergy/Immunology

Treatment of persistent erythema multiforme with JAK inhibition and the role of IFN-γ and IL-15

JAMA | Nov 17, 2021 Derm Allergy/Immunology

« Prev 1 2 3 4 5 6 … 57 Next »

Assessment of changes in color and size of vitiligo lesions during treatment with narrow band ultraviolet B

Risk of progression to autoimmune disease in severe drug eruption: Risk factors and the factor-guided stratification

Safety of tacrolimus 0.03% and 0.1% ointments in young children with atopic dermatitis: A 36-month follow-up study

Efficacy of narrow band UVB with or without OMP in stabilization of vitiligo activity in skin photo-types (III–V): A double-blind, randomized, placebo-controlled, prospective, multicenter study

Association between atopic dermatitis and height, body mass index, and weight in children

Comparison of treatments for H ₁ antihistamine–refractory chronic spontaneous urticaria

Efficacy and safety of oral nalbuphine extended release in prurigo nodularis: Results of a phase 2 randomized controlled trial with an open‐label extension phase

Interleukin 38 serum level is increased in patients with vitiligo, correlated with disease severity, and associated with signs of disease activity

Thalidomide treatment for patients with chronic erythema multiforme

Treatment of persistent erythema multiforme with JAK inhibition and the role of IFN-γ and IL-15

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Top Foods to Combat Winter Illness

Pulmonary Embolism: MCQs Challenge

The Role of Nutrition in Enhancing Fertility for Men and Women

Assessment of changes in color and size of vitiligo lesions during treatment with narrow band ultraviolet B

Risk of progression to autoimmune disease in severe drug eruption: Risk factors and the factor-guided stratification

Safety of tacrolimus 0.03% and 0.1% ointments in young children with atopic dermatitis: A 36-month follow-up study

Efficacy of narrow band UVB with or without OMP in stabilization of vitiligo activity in skin photo-types (III–V): A double-blind, randomized, placebo-controlled, prospective, multicenter study

Association between atopic dermatitis and height, body mass index, and weight in children

Comparison of treatments for H 1 antihistamine–refractory chronic spontaneous urticaria

Efficacy and safety of oral nalbuphine extended release in prurigo nodularis: Results of a phase 2 randomized controlled trial with an open‐label extension phase

Interleukin 38 serum level is increased in patients with vitiligo, correlated with disease severity, and associated with signs of disease activity

Thalidomide treatment for patients with chronic erythema multiforme

Treatment of persistent erythema multiforme with JAK inhibition and the role of IFN-γ and IL-15

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Top Foods to Combat Winter Illness

Pulmonary Embolism: MCQs Challenge

The Role of Nutrition in Enhancing Fertility for Men and Women

Select Specialty

Select Topic

Comparison of treatments for H ₁ antihistamine–refractory chronic spontaneous urticaria